GMS Ventures & Investments - May 27, 2025 SCHEDULE 13D/A Report for Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share (OTLK)

Filing Manager: GMS Ventures & Investments
Reporting Manager: GMS VENTURES & INVESTMENTS
Security: Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share
Symbol: OTLK
Shares outstanding: 57.7M shares
Disclosed Ownership: 29M shares
Ownership: 50.3%
Form type: SCHEDULE 13D/A
Date filed: 5/28/2025, 05:24 PM
Date of event: May 27, 2025
Previous filing: Mar 12, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
GMS VENTURES & INVESTMENTS	50.3%	29M	0	29M	/s/ Lawrence A. Kenyon	Lawrence A. Kenyon/Attorney-in-Fact	0001804598
SUKHTIAN GHIATH M.	50.3%	29M	0	29M	/s/ Lawrence A. Kenyon	Lawrence A. Kenyon/Attorney-in-Fact	0001717441